End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.479 USD | -8.76% | -8.76% | -76.52% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 800
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Patient Services
65.8
%
| 167 | 66.1 % | 214 | 65.8 % | +28.01% |
Dispensary
32.0
%
| 79 | 31.4 % | 104 | 32.0 % | +30.87% |
Clinical Trials & Other
2.1
%
| 6 | 2.5 % | 7 | 2.1 % | +8.58% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 252 | 100.0 % | 324 | 100.0 % | +28.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Virnich
CEO | Chief Executive Officer | 46 | 18-12-31 |
Mihir Shah
DFI | Director of Finance/CFO | 45 | 22-04-03 |
Jeremy Castle
COO | Chief Operating Officer | 41 | 23-09-04 |
Yale Podnos
CTO | Chief Tech/Sci/R&D Officer | 54 | 21-10-31 |
Bradford Hively
BRD | Director/Board Member | 45 | 18-12-31 |
Laura Szitar
HRO | Human Resources Officer | - | - |
Cristina Green
PRN | Corporate Officer/Principal | - | 22-10-10 |
General Counsel | - | 21-11-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Barasch
CHM | Chairman | 70 | 21-11-11 |
Mark Pacala
BRD | Director/Board Member | 68 | 22-09-20 |
Bradford Hively
BRD | Director/Board Member | 45 | 18-12-31 |
Gabe Ling
BRD | Director/Board Member | 42 | 22-08-31 |
Maeve O'Meara
BRD | Director/Board Member | 43 | 21-11-11 |
Mohit Kaushal
BRD | Director/Board Member | 45 | 20-03-09 |
Anne McGeorge
BRD | Director/Board Member | 63 | 21-11-11 |
Karen Johnson
BRD | Director/Board Member | 63 | 21-11-11 |
Karen Johnson
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,171,698 | 50,848,183 ( 66.75 %) | 1,733,774 ( 2.276 %) | 66.61 % |
Stock B | 0 | 165,045 | 0 | 0 |
Company contact information
The Oncology Institute, Inc.
18000 Studebaker Road Suite 800
90703, Cerritos
+
http://www.theoncologyinstitute.comSector
Sales per Business
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.52% | 35.04M | |
+25.52% | 87.77B | |
-24.52% | 70.35B | |
-5.56% | 25.03B | |
+4.31% | 17.73B | |
-14.25% | 16.31B | |
+2.97% | 15.48B | |
+70.11% | 13.52B | |
+79.20% | 13.01B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- TOI Stock
- Company The Oncology Institute, Inc.